The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2019

Filed:

Feb. 26, 2016
Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Shaomeng Wang, Superior Township, MI (US);

Yujun Zhao, Ann Arbor, MI (US);

Bing Zhou, Ann Arbor, MI (US);

Angelo Aguilar, Ann Arbor, MI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 487/14 (2006.01); A61K 31/437 (2006.01); A61K 31/519 (2006.01); C07D 231/38 (2006.01); C07D 261/06 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/519 (2013.01); C07D 231/38 (2013.01); C07D 261/06 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/14 (2013.01);
Abstract

The present disclosure provides substituted 9H-pyrimido [4,5-b] indoles and 5H-pyrido [4,3-b] indoles and related analogs represented by Formula I and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R, W, B, B, G, X, Y, Y, and Yare as defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a condition or disorder responsive to inhibition of BET bromodomains such as cancer. The present disclosure is also directed to the use of compound of Formula I as synthetic intermediates.


Find Patent Forward Citations

Loading…